文献速递甲状腺疾病性腺与生殖内分泌

妊娠期人绒毛膜促性腺激素刺激甲状腺功能:甲状腺疾病的风险因素及已知风险因素的机制

Stimulation of Thyroid Function by Human Chorionic Gonadotropin During Pregnancy: A Risk Factor for Thyroid Disease and a Mechanism for Known Risk Factors.
PubMed 文献 · Thyroid · 2017-02-08

本研究在5435名妊娠妇女的前瞻性队列中测量人绒毛膜促性腺激素(hCG)、促甲状腺激素(TSH)和游离甲状腺素(FT4),发现较高hCG浓度与亚临床和临床甲状腺功能亢进风险升高相关,较低hCG浓度与低甲状腺素血症风险升高相关,hCG浓度与亚临床甲状腺功能减退无关;较高BMI、男性胎儿性别和产次>2与甲状腺对hCG刺激的反应降低相关。

要点

  • 较高hCG浓度与亚临床和临床甲状腺功能亢进风险升高相关。
  • 较低hCG浓度与低甲状腺素血症风险升高相关,hCG与亚临床甲状腺功能减退无关。
  • 较高BMI、男性胎儿性别和产次>2与甲状腺对hCG刺激的反应降低相关。

核心结论

  • hCG与(亚临床)甲状腺功能亢进和低甲状腺素血症的风险相关,但与(亚临床)甲状腺功能减退的风险无关。
  • 低甲状腺素血症妇女对hCG刺激的甲状腺反应正常,而亚临床甲状腺功能减退妇女该反应异常。
  • 已知的甲状腺功能障碍风险因素(BMI和产次)以及男性胎儿性别与甲状腺对hCG刺激的反应降低相关。

研究设计与样本

  • 前瞻性队列研究,纳入5435名妊娠妇女,测量hCG、TSH和FT4,使用多变量线性回归模型分析。

主要发现

  • 较高hCG浓度与亚临床和临床甲状腺功能亢进风险升高相关。
  • 较低hCG浓度与低甲状腺素血症风险升高相关。
  • hCG浓度与亚临床甲状腺功能减退无关。
  • 低甲状腺素血症妇女中,高hCG浓度仍抑制TSH。
  • 亚临床甲状腺功能减退妇女中,高hCG浓度与较高FT4无关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thyroid autoimmunity is a major risk factor for gestational thyroid disease, and recently various other risk factors have been identified, including maternal age, body mass index (BMI) and parity. Human chorionic gonadotropin (hCG) is an important determinant of gestational thyroid function, yet it is unknown to what extent differences in hCG concentration affect the risk for thyroid disease. We have recently shown that thyroperoxidase antibody positivity impairs the thyroidal response to hCG stimulation, which may suggest that this is a mechanism through which thyroid autoimmunity acts as a risk factor for thyroid disease. OBJECTIVE: The purpose of this study is to determine whether hCG is a risk factor for thyroid disease entities and whether recently identified risk factors for thyroid disease may influence the thyroidal response to hCG stimulation. METHODS: Human chorionic gonadotropin, thyrotropin (TSH), and free thyroxine (FT4) were measured in 5435 pregnant women participating in a prospective cohort. The association of hCG with thyroid disease entities, and the association of known risk factors with thyroidal response to hCG stimulation were studied using multivariable linear regression models. RESULTS: Higher hCG concentrations were associated with a higher risk of subclinical and overt hyperthyroidism. Lower hCG concentrations were associated with a higher risk of hypothyroxinemia. In contrast, hCG concentrations were not associated with subclinical hypothyroidism. Further analyses showed that in women with hypothyroxinemia, high hCG concentrations still suppressed TSH. However, in women with subclinical hypothyroidism, high hCG concentrations were not associated with higher FT4. Higher BMI, male fetal sex, and maternal parity >2 were associated with a lower thyroidal response to hCG stimulation. CONCLUSIONS: Human chorionic gonadotropin is associated with the risk of (subclinical) hyperthyroidism and hypothyroxinemia, but not with the risk of (subclinical) hypothyroidism. Women with hypothyroxinemia have a normal response to thyroidal stimulation by hCG, but this was abnormal in women with subclinical hypothyroidism. Known risk factors for thyroid dysfunction (BMI and parity), and also male fetal sex, are associated with a lower thyroidal response to hCG stimulation.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Korevaar TI, de Rijke YB, Chaker L, et al. Stimulation of Thyroid Function by Human Chorionic Gonadotropin During Pregnancy: A Risk Factor for Thyroid Disease and a Mechanism for Known Risk Factors. Thyroid. 2017. PMID: 28049387. doi:10.1089/thy.2016.0527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。